APA

Orekhov A. N., Poznyak A. V., Sobenin I. A., Nikifirov N. N. & Ivanova E. A. (20210726). Mitochondrion as a Selective Target for the Treatment of Atherosclerosis: Role of Mitochondrial DNA Mutations and Defective Mitophagy in the Pathogenesis of Atherosclerosis and Chronic Inflammation. : Current neuropharmacology.

Chicago

Orekhov Alexander N, Poznyak Anastasia V, Sobenin Igor A, Nikifirov Nikita N and Ivanova Ekaterina A. 20210726. Mitochondrion as a Selective Target for the Treatment of Atherosclerosis: Role of Mitochondrial DNA Mutations and Defective Mitophagy in the Pathogenesis of Atherosclerosis and Chronic Inflammation. : Current neuropharmacology.

Harvard

Orekhov A. N., Poznyak A. V., Sobenin I. A., Nikifirov N. N. and Ivanova E. A. (20210726). Mitochondrion as a Selective Target for the Treatment of Atherosclerosis: Role of Mitochondrial DNA Mutations and Defective Mitophagy in the Pathogenesis of Atherosclerosis and Chronic Inflammation. : Current neuropharmacology.

MLA

Orekhov Alexander N, Poznyak Anastasia V, Sobenin Igor A, Nikifirov Nikita N and Ivanova Ekaterina A. Mitochondrion as a Selective Target for the Treatment of Atherosclerosis: Role of Mitochondrial DNA Mutations and Defective Mitophagy in the Pathogenesis of Atherosclerosis and Chronic Inflammation. : Current neuropharmacology. 20210726.